Lir Life Sciences Corp. (CVE:SKNY) | WebDisclosure

Basculer en Français

10776	Companies
232499	Keywords
160975	Articles
123821	Press releases

Headlines Articles Press releases Lir Life Sciences Corp.

Home
Companies
Lir Life Sciences Corp.

BRIEF

published on 07/17/2026 at 00:05, 12 days 14 hours ago

LIR Life Sciences s'associe à Oxygen Handel pour une feuille de route réglementaire

Traitement De L'obésité Administration Transdermique Accord De Développement Thérapeutiques GLP-1 Feuille De Route Réglementaire
BRIEF

published on 07/17/2026 at 00:05, 12 days 14 hours ago

LIR Life Sciences Partners with Oxygen Handel for Regulatory Roadmap

Obesity Treatment Transdermal Delivery Development Agreement GLP-1 Therapeutics Regulatory Roadmap
PRESS RELEASE

published on 07/17/2026 at 00:00, 12 days 15 hours ago

LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline
LIR Life Sciences Corp. enters into a services agreement with Oxygen Handel GmbH to initiate Phase 0 strategic development planning for transdermal metabolic therapeutics pipeline

Regulatory Development Lir Life Sciences Corp. Oxygen Handel GmbH Phase 0 Transdermal Metabolic Therapeutics
BRIEF

published on 06/18/2026 at 00:05, 1 month 11 days ago

LIR Life Sciences dévoile une étude concluante sur la perméation améliorée par la protamine

Résultats De L'étude Thérapies Sans Aiguilles Administration Améliorée Par La Protamine Thérapies À Base De GLP/GIP Sémaglutide Et Tirzépatide
BRIEF

published on 06/18/2026 at 00:05, 1 month 11 days ago

LIR Life Sciences Unveils Successful Study on Protamine-Enhanced Permeation

Study Results Needle-free Therapies Protamine-enhanced Delivery GLP/GIP-based Therapies Semaglutide And Tirzepatide
PRESS RELEASE

published on 06/18/2026 at 00:00, 1 month 11 days ago

LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
LIR Life Sciences Corp. announces successful completion of comparative mouse study evaluating skin-permeation delivery of GLP/GIP-based therapies. Results presented at ENDO 2026

Lir Life Sciences Corp. GLP/GIP-based Therapies Comparative Mouse Study Skin-permeation Delivery ENDO 2026
BRIEF

published on 05/23/2026 at 01:05, 2 months 6 days ago

LIR Life Sciences lance la phase 1 du développement d'un dispositif d'administration transdermique

Administration Transdermique LIR Sciences De La Vie Laboratoires Neuland Phase 1 Du Développement Synthèse De Macromolécules
BRIEF

published on 05/23/2026 at 01:05, 2 months 6 days ago

LIR Life Sciences Initiates Phase 1 Transdermal Delivery Development

Transdermal Delivery LIR Life Sciences Neuland Laboratories Phase 1 Development Macromolecule Synthesis
PRESS RELEASE

published on 05/23/2026 at 01:00, 2 months 6 days ago

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Neuland Laboratories Limited orders raw materials for Phase 1 of macromolecule-enabled transdermal delivery development with LIR Life Sciences Corp. to advance needle-free, skin-applied peptide therapies

Phase 1 Lir Life Sciences Corp. Neuland Laboratories Limited Macromolecule-enabled Transdermal Delivery Needle-free Peptide Therapies
BRIEF

published on 04/29/2026 at 00:05, 3 months ago

LIR Life Sciences lance une étude ex vivo sur l'efficacité de la protamine par voie transdermique.

Accouchement Sans Aiguille Amélioration De La Protamine Transport Transdermique Molécules Thérapeutiques Étude Ex Vivo

1 2 ... 5

Accesswire

Published on 07/29/2026 at 14:30, 30 minutes ago

Stabilis Solutions Announces Second Quarter 2026 Conference Call and Webcast Date
Published on 07/29/2026 at 13:30, 1 hour 30 minutes ago

Audited Annual Statements for the Fiscal Year Ended March 31, 2026
Published on 07/29/2026 at 13:30, 1 hour 30 minutes ago

Sterling Drills Molybdenum Rich Breccia Below MEPS Discovery Intersecting 57 m of 0.81% CuEq Within a Near-Surface 358 m of 0.50% CuEq Including 8.5 m of 4.74% CuEq
Published on 07/29/2026 at 13:10, 1 hour 50 minutes ago

Spirit Blockchain Capital Appoints Judy Galvez as Chief Financial Officer and Provides Corporate Update
Published on 07/29/2026 at 13:10, 1 hour 50 minutes ago

Evergold provides Exploration Update from Golden Lion Project in Toodoggone, British Columbia

View all ACCESSWIRE

EQS Group

Published on 07/29/2026 at 14:55, 5 minutes ago

Monport Final Days of Summer Sale Offers Last Chance Savings on Laser Machines
Published on 07/29/2026 at 14:45, 15 minutes ago

Bison Bank becomes Portugal's first MiCA-Regulated Crypto-Asset Service Provider
Published on 07/29/2026 at 14:45, 15 minutes ago

Bison Bank devient la première banque portugaise agréée MiCA pour fournir des services sur crypto-actifs
Published on 07/29/2026 at 14:40, 20 minutes ago

Dr. Sven K. Weber Succeeds Adriaan Moelker as CEO of BRAIN Biotech AG
Published on 07/29/2026 at 14:39, 21 minutes ago

HELIOS SOLAR AG Successfully Completes Additional Private Placement – Strong Interest from International Investors Following Successful IPO

Les Echos

Published on 07/29/2026 at 12:05, 2 hours 55 minutes ago

CNP Assurances wins the call for tenders for the personal risk insurance of 62,000 employees of the City of Paris and its partners
Published on 07/29/2026 at 12:05, 2 hours 55 minutes ago

CNP Assurances remporte l’appel d’offres pour la prévoyance des 62 000 agents de la Ville de Paris et de ses partenaires
Published on 07/29/2026 at 08:30, 6 hours 30 minutes ago

SUEZ delivers a solid first half of 2026
Published on 07/29/2026 at 08:30, 6 hours 30 minutes ago

SUEZ réalise un 1er semestre 2026 solide
Published on 07/29/2026 at 08:15, 6 hours 45 minutes ago

Winamp Announces Strategic Partnership with Deezer to Power the Next Generation of Its Iconic Music Player

View all LES ECHOS COMFI WIRE